Preparation and identification of monoclonal antibodies against Penicillium marneffei]

OBJECTIVE: To prepare and identify monoclonal antibodies (mAbs) against Penicillium marneffei. METHODS: Recombinant mannoprotein1 (MP1) of Penicillium marneffei was used to immunize BALB/c mice, and anti-MP1 mAbs were obtained by means of hybridoma. Screening and identification of the mAbs were subsequently performed with indirect enzyme-linked immunosorbent assay and Western blotting, respectively. RESULTS: Four hybridomas producing antibodies against Penicillium marneffei were obtained, and the IgG isotypes of the 4 mAbs were identified as IgG1 with affinity constants (K) of 8.2x10(-9), 4.7x10(-9), 6.5x10(-9) and 2.7x10(-9), respectively. Western blotting demonstrated specific recognition of Aspergillus fumigatus MP1 by the obtained mAbs. CONCLUSION: The 4 hybridomas producing anti-MP1 mAbs with high specificity and affinity can be of significant value in the diagnosis of Penicilliosis marneffei infections.     

高压氧治疗对脑梗死患者血清基质金属蛋白酶-9的影响

目的探讨高压氧（HBO）治疗后急性脑梗死患者血清基质金属蛋白酶-9（MMP-9）水平的动态变化及其与临床疗效的关系。方法选取首次发病的24h以内的颈内动脉系统急性脑梗死患者76例，分为高压氧治疗组（HBO组，36例）和常规治疗组（常规组，40例）。常规组仅给予常规治疗，HBO组在常规治疗基础上加用HBO治疗。30例年龄、性别与脑梗死患者相匹配的健康人为健康对照组（正常对照组）。采用酶联免疫吸附双抗体夹心法测定脑梗死患者入院时、发病后第3、5、10天以及正常对照组血清MMP-9。所有患者于入院时和治疗后10d、1个月进行神经功能缺损评分，评价HBO组和常规组之间的疗效差异。结果（1）与正常对照组比较，HBO组和常规组入院时血清MMP-9的浓度均明显增高，差异有统计学意义（P〈0.01），但后二者之间差异无统计学意义（P〉0.05）。与治疗前相比，常规组和HBO组血清MMP-9水平均呈现先增高后降低的动态变化趋势，3d时达高峰，在治疗后3、5d时HBO组血清MMP-9浓度低于同期常规组（P〈0．05）。（2）治疗1个月后，神经功能缺失评分HBO组明显低于常规组；HBO组疗效优于常规组（P〈0．05）。（3）脑梗死患者神经功能缺损评分减少值与患者发病后第3天之血清MMP-9水平呈显著负相关。结论HBO治疗能降低脑梗死患者升高的血清MMP-9浓度，减轻神经功能缺失程度，其临床疗效可能与降低患者血清MMP-9的浓度有关。     

高效液相色谱法测定峰丁麻滴眼剂中盐酸麻黄碱含量

目的　建立高效液相色谱法测定蜂丁麻滴眼剂中盐酸麻黄碱含量的方法。　方法　采用YWGC18分析色谱柱 ( 4 6mmID× 2 5 0mm ,粒径 10 μm) ,C18保护柱 ( 4 6mmID× 5mm ,粒径 10 μm) ,流动相 10 %乙腈 ( 0 5 %三乙胺 ,磷酸调pH3 0 ) ,流速 1 0ml/min ,检测波长 2 0 8nm ,测定对照品和样品色谱图 ,记录盐酸麻黄碱色谱峰面积 ,计算其含量。　结果　盐酸麻黄碱的理论板数为 10 0 0 0。回归方程 :y =90 5 878 16 15 1738x ,r=0 9999,线性范围 0 4 0 32～ 1 6 13μg。平均回收率为 99 2 % (RSD1 6 % )。　结论　该法操作简便 ,结果准确 ,可用于测定蜂丁麻滴眼剂中盐酸麻黄碱的含量     

针刺对海洛因依赖的脱毒疗效及其防复吸潜力的临床研究

目的 比较针刺、针刺加阿片、阿片加丁丙诺啡及阿片加韩氏戒毒仪4种方法的脱毒疗效及其对脱毒末期稽延性戒断症状和心理渴求的影响。方法 应用戒断症状量表观察脱毒疗效，应用视觉类比量表(VAS)研究心理渴求程度。结果 针刺改善海洛困依赖者戒断症状的优势主要表现在治疗的第6天以后，改善渴求心理的优势表现在第8天以后，且无明显副作用。结论 针刺具有防复吸潜力。可作为解决稽延性戒断症状和消除心理依赖的治疗方法。     

MR扩散加权成像鉴别脑结核瘤及高级星形细胞瘤和脑转移瘤的价值

目的探讨MR扩散加权成像（DWI）在脑结核瘤、高级星形细胞瘤和脑转移瘤鉴别诊断中的价值。方法14例脑结核瘤、15例脑高级星形细胞瘤和21例脑转移瘤患者，在术前或接受治疗前行常规MRI和DWI。测量并计算3种疾病瘤体、瘤周围水肿带的平均表观扩散系数（ADC）值和病灶与对侧相应部位正常脑白质区ADC值的比值（rADC值）。结果脑结核瘤瘤体平均ADC值和rADC值分别为（1．2±0．2）×10^-3mm^2·s^-1和1．6±0．3，高级星形细胞瘤瘤体平均ADC值和rADC值分别为（0．8±0．1）×10^-3mm^2·s^-1和1．1±0．1，转移瘤瘤体平均ADC值和rADC值分别为（0．8±0．1）×10^-3mm^2·s^-1和1．0±0．2。3种疾病瘤体平均ADC值（F=33．57，P〈0．01）之间和rADC值（F=33．27，P〈0．01）之间差异均有统计学意义。脑结核瘤瘤周水肿带平均ADC值和rADC值分别为（1．8±0．1）×10^-3mm^2·s^-1和2．5±0．2，脑高级星形细胞瘤瘤周水肿带平均ADC值和rADC值分别为（1．4±0．2）×10^-3mm^2·s^-1和1．8±0．3，脑转移瘤瘤周水肿带平均ADC值和rADC值分别为（1．9±0．2）×10^-3mm^2·s^-1和2．3±0．5。3种疾病瘤周围水肿带平均ADC值（F=23．17，P〈0．01）之间和rADC值（F=5．94，P〈0．01）之间差异均有统计学意义。结论结合MRI、DWI检测方法，根据病灶瘤体和瘤周水肿带的ADC和rADC值可帮助鉴别脑结核瘤、脑高级星形细胞瘤和脑转移瘤。     

人本管理理念在军队医院合同护士管理中的应用

对58例下肢静脉曲张患者行大隐静脉高位结扎术联合腔内激光治疗，结果治疗效果满意，术后平均住院5.0d，未发生并发症，随访2年无复发。提出加强术前、术后护理及康复指导，对帮助患者顺利进行手术，促进康复，预防复发有重要意义。     

The Role of Donor Bone Marrow Infusions in Withdrawal of Immunosuppression in Adult Liver Allotransplantation

We investigated the role of donor bone marrow cell (DBMC) infusions in immunosuppression withdrawal in adult liver transplantation. Patients enrolled were at least 3 years post-transplantation, with stable graft function. Forty-five (study group: G1) received DBMC, and 59 (control group: G2) did not. Immunosuppression was reduced by one third upon enrollment, by another third the second year of the study and was completely withdrawn the third year. Patient and graft survival were similar between the two groups. Although rejection episodes were significantly less in G1 the first 2 years of the study (35% vs. 57%, p = 0.016), there was no significant difference overall (74% vs. 81%, p = 0.14). Until February 2004, 20 patients, 10 in each group, were immunosuppression free for 1-3 years. Approximately 20% of long-term survivors of liver transplantation can successfully discontinue their immunosuppression. DBMC infusions, do not increase this likelihood.